Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biocorrx Inc. stock logo
BICX
Biocorrx
$0.25
+19.0%
$0.27
$0.15
$1.28
$7.52M0.192,895 shs1,000 shs
Bioqual Inc. stock logo
BIOQ
Bioqual
$33.00
$32.62
$32.50
$43.55
$29.52M-0.261 shsN/A
Cosmos Health Inc. stock logo
COSM
Cosmos Health
$0.25
-0.7%
$0.23
$0.16
$1.32
$25.66M4.82.56 million shs1.23 million shs
111, Inc. Sponsored ADR stock logo
YI
111
$3.45
+10.2%
$3.69
$2.48
$11.17
$27.50M0.648,970 shs35,654 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biocorrx Inc. stock logo
BICX
Biocorrx
0.00%+19.05%-10.71%-34.21%-44.32%
Bioqual Inc. stock logo
BIOQ
Bioqual
0.00%0.00%+1.54%+1.54%-24.23%
Cosmos Health Inc. stock logo
COSM
Cosmos Health
-0.71%-4.92%+15.20%+20.57%-66.68%
111, Inc. Sponsored ADR stock logo
YI
111
+10.22%+4.99%-8.49%-29.45%-42.88%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biocorrx Inc. stock logo
BICX
Biocorrx
$0.25
+19.0%
$0.27
$0.15
$1.28
$7.52M0.192,895 shs1,000 shs
Bioqual Inc. stock logo
BIOQ
Bioqual
$33.00
$32.62
$32.50
$43.55
$29.52M-0.261 shsN/A
Cosmos Health Inc. stock logo
COSM
Cosmos Health
$0.25
-0.7%
$0.23
$0.16
$1.32
$25.66M4.82.56 million shs1.23 million shs
111, Inc. Sponsored ADR stock logo
YI
111
$3.45
+10.2%
$3.69
$2.48
$11.17
$27.50M0.648,970 shs35,654 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biocorrx Inc. stock logo
BICX
Biocorrx
0.00%+19.05%-10.71%-34.21%-44.32%
Bioqual Inc. stock logo
BIOQ
Bioqual
0.00%0.00%+1.54%+1.54%-24.23%
Cosmos Health Inc. stock logo
COSM
Cosmos Health
-0.71%-4.92%+15.20%+20.57%-66.68%
111, Inc. Sponsored ADR stock logo
YI
111
+10.22%+4.99%-8.49%-29.45%-42.88%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biocorrx Inc. stock logo
BICX
Biocorrx
0.00
N/AN/AN/A
Bioqual Inc. stock logo
BIOQ
Bioqual
0.00
N/AN/AN/A
Cosmos Health Inc. stock logo
COSM
Cosmos Health
1.00
SellN/AN/A
111, Inc. Sponsored ADR stock logo
YI
111
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest BICX, YI, BIOQ, and COSM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/31/2026
111, Inc. Sponsored ADR stock logo
YI
111
DowngradeSell (D-)Sell (E+)
8/14/2026
111, Inc. Sponsored ADR stock logo
YI
111
UpgradeSell (E+)Sell (D-)
7/30/2026
Cosmos Health Inc. stock logo
COSM
Cosmos Health
UpgradeSell (E+)Sell (D-)
7/2/2026
111, Inc. Sponsored ADR stock logo
YI
111
DowngradeSell (D-)Sell (E+)
6/18/2026
111, Inc. Sponsored ADR stock logo
YI
111
UpgradeSell (E+)Sell (D-)
6/15/2026
Cosmos Health Inc. stock logo
COSM
Cosmos Health
Reiterated RatingSell (E+)
(Data available from 9/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biocorrx Inc. stock logo
BICX
Biocorrx
$800K9.40N/AN/A($0.47) per share-0.53
Bioqual Inc. stock logo
BIOQ
Bioqual
$48.87M0.60$1.48 per share22.33$40.42 per share0.82
Cosmos Health Inc. stock logo
COSM
Cosmos Health
$65.27M0.39N/AN/A$0.45 per share0.56
111, Inc. Sponsored ADR stock logo
YI
111
$1.80B0.02N/AN/A($11.74) per share-0.29
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biocorrx Inc. stock logo
BICX
Biocorrx
-$3.44M-$0.12N/AN/AN/AN/AN/A-90.89%11/17/2026 (Estimated)
Bioqual Inc. stock logo
BIOQ
Bioqual
-$1.05M-$1.08N/AN/AN/A-2.27%-2.69%-1.50%N/A
Cosmos Health Inc. stock logo
COSM
Cosmos Health
-$19.15M-$0.64N/A3.62N/A-33.08%-56.88%-18.03%11/13/2026 (Estimated)
111, Inc. Sponsored ADR stock logo
YI
111
-$9.65M-$1.40N/AN/AN/A-0.76%N/A-3.80%11/26/2026 (Estimated)

Latest BICX, YI, BIOQ, and COSM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/19/2026Q2 2026
Cosmos Health Inc. stock logo
COSM
Cosmos Health
-$0.10-$0.10N/A-$0.10$18.99 million$19.32 million
8/14/2026Q2 2026
Biocorrx Inc. stock logo
BICX
Biocorrx
-$0.05-$0.03+$0.02-$0.03$0.24 million$0.09 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Biocorrx Inc. stock logo
BICX
Biocorrx
N/AN/AN/AN/AN/A
Bioqual Inc. stock logo
BIOQ
Bioqual
N/AN/AN/AN/AN/A
Cosmos Health Inc. stock logo
COSM
Cosmos Health
N/AN/AN/AN/AN/A
111, Inc. Sponsored ADR stock logo
YI
111
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biocorrx Inc. stock logo
BICX
Biocorrx
N/A
0.07
0.07
Bioqual Inc. stock logo
BIOQ
Bioqual
N/A
4.01
4.01
Cosmos Health Inc. stock logo
COSM
Cosmos Health
0.15
1.05
0.92
111, Inc. Sponsored ADR stock logo
YI
111
N/A
1.08
0.49

Institutional Ownership

CompanyInstitutional Ownership
Biocorrx Inc. stock logo
BICX
Biocorrx
N/A
Bioqual Inc. stock logo
BIOQ
Bioqual
N/A
Cosmos Health Inc. stock logo
COSM
Cosmos Health
12.61%
111, Inc. Sponsored ADR stock logo
YI
111
21.32%

Insider Ownership

CompanyInsider Ownership
Biocorrx Inc. stock logo
BICX
Biocorrx
21.40%
Bioqual Inc. stock logo
BIOQ
Bioqual
39.24%
Cosmos Health Inc. stock logo
COSM
Cosmos Health
26.15%
111, Inc. Sponsored ADR stock logo
YI
111
43.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biocorrx Inc. stock logo
BICX
Biocorrx
330.09 million23.65 millionNot Optionable
Bioqual Inc. stock logo
BIOQ
Bioqual
114890,000543,000Not Optionable
Cosmos Health Inc. stock logo
COSM
Cosmos Health
100100.63 million74.32 millionOptionable
111, Inc. Sponsored ADR stock logo
YI
111
1,0638.79 million4.93 millionOptionable

Recent News About These Companies

111 Inc. ADR
111, Inc. Sponsored ADR
111: Q1 Earnings Snapshot
111: Q4 Earnings Snapshot
111: Q3 Earnings Snapshot
111: Q2 Earnings Snapshot
111 Inc Share Price | NASDAQ: YI Stock - Investing.com UK

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Biocorrx stock logo

Biocorrx OTCMKTS:BICX

$0.25 +0.04 (+19.05%)
As of 09/10/2026 09:30 AM Eastern

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

Bioqual stock logo

Bioqual OTCMKTS:BIOQ

$33.00 0.00 (0.00%)
As of 09/9/2026

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

Cosmos Health stock logo

Cosmos Health NASDAQ:COSM

$0.25 0.00 (-0.71%)
Closing price 09/10/2026 04:00 PM Eastern
Extended Trading
$0.26 +0.00 (+1.11%)
As of 07:33 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

111 stock logo

111 NASDAQ:YI

$3.45 +0.32 (+10.22%)
Closing price 09/10/2026 03:53 PM Eastern
Extended Trading
$3.32 -0.14 (-3.91%)
As of 07:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.